Down almost 50% from all-time highs, Roblox stock trades at a discount to consensus price target estimates in January 2026.
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) stock declines while market improves: Some information for investors
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $54.21, marking a -4.71% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.26%. At the ...
Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...
Money Talks News on MSN
CRISPR cures cholesterol, FDA demands testing
Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...
Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr.
UCSF scientists engineered old fibroblast cells to turn their genes on and off in the same way as young fibroblasts. The old ...
Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.
Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism.
A research team led by Associate Professor Hirofumi Nishizono and graduate student Masaki Kato from the Research Support ...
CRISPR Therapeutics analysis: long-term upside despite volatility. Track Casgevy ramp, pipeline milestones & cash runway.
CEO and cofounder of Earli, a Silicon Valley-based cancer therapeutics firm that creates genetic switches that only turn on ...
Therapeutic Potential of CRISPR–Cas3 Genome-Editing System for Transthyretin Amyloidosis. Credit: Institute of Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results